Estimating the Economic Burden of Lung Cancer in Iran
نویسندگان
چکیده
Objectives: Lung cancer is a major public health problem and one of the most costly illnesses. The study aimed to estimate the economic burden of lung cancer in Iran in 2014. Methods: A cross-sectional study was conducted to estimate the direct and indirect costs for patients with lung cancer using a prevalence-based approach. A human capital approach was employed to estimate the indirect costs. Data were obtained from several sources such as through patient interview using structured questionnaire, medical records, the GLOBOCAN databases, the Iranian Statistical Center, the Iranian Ministry of Cooperation, Labor and Social Welfare, and the Institute for Health Metrics and Evaluation (IHME). Results: The economic burden of lung cancer in Iran in the year 2014 was 3,225,998,555,090 IR. The main components of the cost were associated with mortality (81.9 %) and hospitalization (7.6 %). The costs of direct medical care, non-medical aspects, patient time, and mortality accounted for 10.8%, 2.7%, 4.5%, and 81.5% of the total cost, respectively. Conclusion: Findings from this study indicated that the economic burden of lung cancer is substantial both to Iran’s health system and to society as a whole. Early diagnosis, strengthening cancer prevention, implementing new cancer therapy and medical technology, and effective smoking-cessation interventions could offset some of the costs associated with lung cancer in Iran.
منابع مشابه
Economic burden of colorectal cancer in Iran in 2012
Background: Colorectal cancer is one of the most common cancers in Iran. However little is known about the economic burden associated with this cancer in Iran. The aim of this study was to estimate the economic burden of colorectal cancer in Iran in the year 2012. Methods: We used the prevalence-based approach and estimated direct and indirect costs of all color...
متن کاملبررسی هزینههای بیماری سرطان درکرمان
Background ; Objectives: The economic costs of cancer care are a burden to people diagnosed with cancer, their families, and society as a whole. Despite several studies about cancer in Iran, there is paucity of cost analysis in this area. The aim of this study was to estimate the cost of cancer subgroups in Kerman, Iran. Methods: A retrospective analysis of administrative 223 diagnosed pa...
متن کاملEconomic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach
Objectives: The burden of smoking on the health system and society is significant. The current study aimed to estimate the annual direct and indirect costs of smoking in Iran for the year 2014. Methods: A prevalence-based diseasespecific approach was used to determine costs associated with the three most common smoking-related diseases: lung cancer (LC), chronic obstructive pulmonary disease (C...
متن کاملThe Economic Burden of Breast Cancer in Iran
BACKGROUND Although breast cancer imposes a considerable economic burden on high-income countries, there is limited knowledge about its economic burden in low- and middle-income countries (LMCs), including Iran. In this study, we estimated the economic burden of breast cancer in Iran in 2010. METHODS We used the prevalence-based approach and estimated the direct and indirect costs of all brea...
متن کاملتخمین نرخ بروز استاندارد شده سنی سرطان ریه در ایران برای سالهای 2014 و 2030
Introduction: lung cancer is the most deadly and the most expensive cancer all around the world. Limited studies have been conducted in the survey of incidence rate for lung cancer in IRAN. National report of cancer registry in IRAN (report 2008) indicates that mean value of ASR of lung cancer is 5.23 for men and women (7.09 for men and 3.38 for women). These values are so different from the va...
متن کامل